September 16 - 19, 2015
Sheraton New York Times Square Hotel
New York, New York, USA
Abstract submission deadline: Wednesday, June 10
Advance registration deadline: Monday, July 27
Meet the Editors7:00 a.m.-8:00 a.m.
Cancer Immunology, ImmunotherapyGraham P. Pawelec, Editor-in-ChiefSuzanne Ostrand-Rosenberg, Editor-in-Chief
Cancer Immunology ResearchRobert D. Schreiber, Editor-in-ChiefPhilip D. Greenberg, Editor-in-ChiefLinda J. Miller, Executive Editor
OncoImmunologyGuido Kroemer, Editor-in-ChiefLaurence Zitvogel, Editor-in-ChiefLorenzo Galluzzi, Editor-in-Chief
Plenary Session 5: Immunotherapy of Persistent Viral Infections and Virus-1 Induced CancersSession Chairperson: Cornelis J.M. Melief, Leiden University Medical Center and ISA Pharmaceuticals BV, Leiden, The Netherlands 8:00 a.m.-9:40 a.m.
Chairperson perspectiveCornelis J.M. Melief
Immunotherapy with virus-specific T cellsHelen Heslop, Baylor College of Medicine, Houston, Texas
T cell memory and exhaustionRafi Ahmed, Emory University, Atlanta, Georgia
Refreshment Break9:40 a.m.-10:10 a.m.
Plenary Session 6: BiomarkersSession Chairperson: Ira Mellman, Genentech, South San Francisco, California10:10 a.m.-12:40 p.m.
Chairperson perspective: Biomarkers and mechanism in immunotherapyIra Mellman
Immune checkpoint therapy: Immune monitoring on presurgical and tissue-based clinical trialsPadmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, Texas
Antigenome and immune contexture in cancerJerome Galon,
Cordeliers Research Center (INSERM), Paris, France
Genomic assessment of tumor immune profilesChristian Ottensmeier, University of Southampton, Southampton, United Kingdom
Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent mannerRikke B. Holmgaard, Memorial Sloan-Kettering Cancer Center, Ludwig Cancer Research, New York, New York
Imaging and Targeting of the Antitumor Response
12:40 p.m.-2:10 p.m.
Immunological insights from tracking dynamic cellular behavior in lymph nodes and tissuesAlex Yee-Chen Huang, Case Western Reserve University School of Medicine, Cleveland, Ohio
Towards synthetic immune cells for cancer immunotherapyCarl G. Figdor, Nijmegen Centre for Molecular Life Sciences (NCMLS), Nijmegen, The Netherlands
Imaging immunity: Creating a quantitative spatiotemporal understanding of host defense and anti-tumor responsesRonald N. Germain, National Institute of Allergy and Infectious Disease, NIH, Bethesda, Maryland
General Lunch12:40 p.m.-2:10 p.m.
Concurrent Sessions 1-22:25 p.m.-4:25 p.m.
Session Chairperson to be announced
Gut microbiota regulates anti-cancer immune responses Laurence Zitvogel, Gustave Roussy Cancer Center, Villejuif, France
Commensal microorganisms and polymorphic mucosal surfaces determine the evolution of distal metastatic tumorsJose R. Conejo-Garcia, The Wistar Institute, Philadelphia, Pennsylvania
Biofilms, genetics and colon cancerCynthia L. Sears, Johns Hopkins University, Baltimore, Maryland
Tracking microbial sensing in colorectal cancer using bioorthogonal click chemistry*Jason Hudak, Harvard Medical School, Boston, Massachusetts
Concurrent Session 2: Companion Diagnostics: Assay HarmonizationSession Chairperson:
Axel Hoos, GlaxoSmithKline Pharmaceuticals, Collegeville,
Title to be announcedAbigail McElhinny, Ventana Medical Systems, Inc., Tucson, Arizona
Title to be announcedRobert A. Anders, Johns Hopkins University School of Medicine, Baltimore, Maryland
Title to be announcedPaul Tumeh, UCLA Medical Center, Los Angeles, California
Title to be announcedKenneth Bloom, GE Healthcare, Aliso Viejo, California
Panel Discussion3:45 p.m.-4:45 p.m.
Robert A. Anders, Johns Hopkins University School of Medicine, Baltimore, Maryland
Kenneth Bloom, GE Healthcare, Aliso Viejo, California
Axel Hoos, GlaxoSmithKline Pharmaceuticals, Collegeville, Pennsylvania
Ian McCaffery, Genentech, South San Francisco,
Abigail McElhinny, Ventana Medical Systems, Inc., Tucson, Arizona
Jim Novotny, Bristol-Myers Squibb, Princeton, New Jersey
Reena Philip, Food and Drug Administration Center for Devices and Radiological Health, Silver Spring, Maryland
Dave Stanforth, Dako North America - Agilent Technologies, Carpinteria,
Paul Tumeh, UCLA Medical Center, Los Angeles, California
Poster Session B4:45 p.m.-6:45 p.m.
*Short talks from proffered abstracts
Top of page